Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension studyEdward V. Loftus, Irina Blumenstein, Vipul Jairath et al.|Journal of Crohn s and Colitis|2025Cited by 8
Upadacitinib Maintenance Therapy in Crohn’s Disease: Final Results From the Randomized Phase 3 U-ENDURE StudyRemo Panaccione, Julián Panés, Miguel Regueiro et al.|Clinical Gastroenterology and Hepatology|2025Cited by 4